Improvement in the colloidal stability of protein kinase-responsive polyplexes by PEG modification

Journal of Biomedical Materials Research. Part a
Akira TsuchiyaYoshiki Katayama

Abstract

We have reported a disease-cell specific gene expression system that is responsive to intracellular signaling proteins (e.g., protein kinases and proteases) hyperactivated in diseased cells. For this system, cationic peptide-grafted polymers were synthesized for polyplex formation with genes. Here, we modified poly(ethylene glycol) (PEG) to a protein kinase A (PKA)-responsive polymer to improve polyplex stability. PEG modification neutralized the surface charge of the polyplex and successfully increased polyplex stability at physiological conditions. However, PEG modification (PEG contents, 0.6 and 3.3 mol %) showed almost negligible effects on the reactivity of grafted peptides to PKA and the promotion of gene expression responding to PKA activity. Excessive modification of PEG (PEG contents, 6.8 mol %) inhibited polyplex formation. These results indicate that moderate modification of PEG to the enzyme-responsive polymer improves polyplex stability without inhibiting the reaction with enzymes.

References

Nov 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P C GordgeW R Miller
Sep 19, 1998·Journal of Controlled Release : Official Journal of the Controlled Release Society·C W PoutonS H Moss
Aug 10, 2000·Neoplasia : an International Journal for Oncology Research·C C CarlsonD T Dransfield
Nov 29, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Jun OishiYoshiki Katayama
Jan 5, 2008·Bioconjugate Chemistry·Markus RimannHeike Hall
Feb 12, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Srinivas GantaMansoor Amiji
Feb 29, 2008·Journal of Pharmaceutical Sciences·Uta Wattendorf, Hans P Merkle
Apr 10, 2008·Journal of the American Chemical Society·Seiji TakaeKazunori Kataoka
May 1, 2008·Journal of Drug Targeting·Tomoko ItoYoshiyuki Koyama
Jul 4, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Oju JeonByung-Soo Kim
Oct 22, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Young Tag KoVladimir P Torchilin
Mar 21, 2009·Bioorganic & Medicinal Chemistry·Amir H Faraji, Peter Wipf
May 9, 2009·The Journal of Gene Medicine·Daisuke AsaiYoshiki Katayama
Nov 26, 2009·Bioorganic & Medicinal Chemistry·Widchaya RadchatawedchakoonBoon-ek Yingyongnarongkul
May 18, 2010·Bioorganic & Medicinal Chemistry·Takuro NiidomeYoshiki Katayama
Aug 18, 2010·Journal of the American Chemical Society·Kensuke OsadaKazunori Kataoka
Aug 24, 2010·Journal of Controlled Release : Official Journal of the Controlled Release Society·Tetsuro TomiyamaYoshiki Katayama
May 19, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Akira TsuchiyaYoshiki Katayama

❮ Previous
Next ❯

Citations

Aug 29, 2012·International Journal of Nanomedicine·Masaharu MurataMakoto Hashizume
Jan 28, 2014·Journal of Biomaterials Science. Polymer Edition·Guo Xi ZhaoYoshiki Katayama
May 4, 2021·Chemical Reviews·Ramya KumarTheresa M Reineke

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.